Assorted news from the last week: Children conceived via assisted reproductive technology (ART) were not at increased risk of developing cancer later on, according to results of a prospective study. More than a third of adolescent and young adult (AYA) cancer survivors reported being hesitant about vaccination against COVID-19 in a survey conducted in Utah and surrounding Mountain West states. The FDA approved a recombinant form of a key component of a chemotherapy regimen for acute lymphoblastic leukemia (ALL), the most common childhood cancer. The approval of recombinant asparaginase erwinia chrysanthemi-rywn (Rylaze) encompasses treatment regimens for adults and pediatric patients […]
Read moreAssorted news from the last week: U.S. News & World Report released this year’s rankings of the top pediatric cancer hospitals in the United States. National Cancer Institute Director Ned E. Sharpless assesses how far we’ve come in the fight against cancer in 50 years and how much further we can go in the next 50. New research uncovers substantial differences in rates of childhood cancers when considering single year of age rather than grouping several years together. Study suggests that the chemotherapy regimen used for treating high risk neuroblastoma patients by the European Neuroblastoma Study Group is equally efficacious […]
Read moreAssorted news from the last week: Survivors of childhood cancers are at increased risk for prescription opioid misuse compared with their peers, a review of a claims database revealed. A panel of pediatric cancer specialists endorsed the first-ever consensus recommendations for end-of-life care for children with cancer and their families. Serious Long-Term Adverse Events Decreased in Pediatric Hodgkin Lymphoma Auburn men’s basketball coach Bruce Pearl and Florida football coach Dan Mullen were among the personalities on hand Friday night in Sarasota, Florida to help ESPN college basketball analyst Dick Vitale raise $5 million at a gala to support pediatric cancer […]
Read more